Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney

American Journal of Physiology - Renal Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Fujihara, Clarice Kazue ^a   Malheiros, Denise Maria Avancini Costa ^a   Donato, José Luís ^b   Poli, Anicleto ^b   De Nucci, Gilberto ^b   Zatz, Roberto ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Laboratorio de Fisiopatologia Renal   (Brazil)

Author keywords

Chronic pathophysiology; Cyclooxygenase; Glomerulosclerosis; Kidney failure; Non steroidal anti inflammatory drugs; Renal ablation

Indexed keywords

FLURBIPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME SYNTHESIS; GASTROINTESTINAL MUCOSA; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; KIDNEY INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0031897299     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1998.274.3.f573     Document Type: Article

References (30)

1. Agarwal, A., and K. A. Nath. Effect of proteinuria on renal interstitium: effects of products of nitrogen metabolism. Am. J. Nephrol. 13: 376-384, 1993.
2. Arima, S., Y. Ren, L. A. Juncos, O. A. Carretero, and S. Ito. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int. 45: 650-658, 1994.
3. Ashab, I., G. Peer, M. Blum, Y. Wollman, T. Chernihovsky, A. Hassner, D. Schwartz, S. Cabili, D. Silverberg, and A. Iaina. Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int. 47: 1515-1521, 1995.
4. Bruggeman, L. A., E. A. Horigan, S. Horikoshi, P. E. Ray, and P. E. Klotman. Thromboxane stimulates synthesis of extracellular matrix proteins in vitro. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): F488-F494, 1991.
5. Corna, D., M. Noris, E. Luzzana, A. Benigni, C. Zoja, M. Todeschini, and G. Remuzzi. A nitric oxide (NO)-donor either as prophylaxis or therapy slows renal disease progression and prolongs survival in remnant kidney (RMR) (Abstract). J. Am. Soc. Nephrol. 7: 1852, 1996.
6. Daniels, B. S., and T. H. Hostetter. Adverse effects of growth in the glomerular microcirculation. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F1409-F1416, 1990.
7. Fries, J. W. U., D. J. Sandstrom, T. W. Meyer, and H. G. Rennke. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab. Invest. 60: 205-218, 1989.
8. Garcia, D. L., S. Anderson, H. G. Rennke, and B. M. Brenner. Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass. Proc. Natl. Acad. Sci. USA 85: 6142-6146, 1988.
9. Harris, R. C., M. A. Haralson, and K. F. Badr. Continuous stretch-relaxation in culture alters rat mesangial cell morphology, growth characteristics, and metabolic activity. Lab. Invest. 66: 548-554, 1992.
10. Heinegard, D., and G. Tiderstrom. Determination of serum creatinine by direct colorimetric method. Clin. Chim. Acta 43: 305-310, 1973.
11. Hirose, K., R. Ysterby, M. Nozawa, and H. J. G. Gundersen. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int. 21: 689-695, 1982.
12. Huskisson, E. C., R. Ghozlan, R. Kurthen, F. L. Degner, and E. Bluhmki. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis. Br. J. Rheumatol. 5, Suppl. 1: 29-34, 1996.
13. Jaffer, S., J. Mattana, and P. C. Singhal. Effects of prostaglandin E2 on mesangial cell migration. Am. J. Nephrol. 15: 300-305, 1995.
14. Jepsen, F. L., and P. B. Mortensen. Interstitial fibrosis of the renal cortex in minimal change lesion and its correlation with renal function. A quantitative study. Virchows Arch. 383: 265-270, 1979.
15. Klahr, S., G. Schreiner, and I. Ichikawa. The progression of renal disease. N. Engl. J. Med. 318: 1657-1666, 1988.
16. Mahadevan, P., R. G. Larkins, J. R. Fraser, and M. E. Dunlop. Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes. Diabetes 45: 44-50, 1996.
17. Nath, K. A., D. H. Chmielewski, and T. H. Hostetter. Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F829-F837, 1987.
18. Neuringer, J. R., and B. M. Brenner. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am. J. Kidney Dis. 22: 98-104, 1993.
19. Olson, J. L., T. H. Hostetter, H. G. Rennke, B. M. Brenner, and M. A. Venkatachalam. Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int. 22: 112-126, 1982.
20. Purkerson, M. L., J. H. Joist, J. Yates, A. Valdes, A. Morrison, and S. Klahr. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc. Natl. Acad. Sci. USA 82: 193-197, 1985.
21. Remuzzi, A., and G. Remuzzi. The effects of nonsteroidal anti-inflammatory drugs on glomerular nitration of proteins and their therapeutic utility. Semin. Nephrol. 15: 236-243, 1995.
22. Ribeiro, M. O., E. Antunes, G. De-Nucci, S. M. Lovisolo, and R. Zatz. Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 20: 298-303, 1992.
23. Sachinidis, A., M. Flesch, Y. Ko, K. Schror, R. Bohm, R. Dusing, and H. Vetter. Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension 26: 771-780, 1995.
24. Tapp, D. C., W. G. Wortham, J. F. Addison, D. N. Hammonds, J. L. Barnes, and M. A. Venkatachalam. Food restriction retards body growth and prevents end-stage renal pathology in remnant kidneys regardless of protein intake. Lab. Invest. 60: 184-195, 1989.
25. Vane, J. R., J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91: 2046-2050, 1994.
26. Wallace, J. L., B. Reuter, C. Cicala, W. McKnight, M. B. Grisham, and G. Cirino. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107: 173-179, 1994.
27. Wallenstein, S., C. L. Zucker, and J. L. Fleiss. Some statistical methods useful in circulation research. Circ. Res. 47: 1-9, 1980.
28. Weibel, E. R. Stereological Methods. In: Practical Methods for Biological Morphometry. London: Academic, vol. 1, 1979.
29. Zatz, R. A low-cost tail-cuff method for the estimation of mean arterial pressure in conscious rats. Lab. Anim. Sci. 40: 198-201, 1990.
30. Zoja, C., N. Perico, D. Corna, A. Benigni, M. Gabanelli, M. Morigi, T. Bertani, and G. Remuzzi. Thromboxane synthesis inhibition increases renal prostacyclin and prevents renal disease progression in rats with remnant kidney. J. Am. Soc. Nephrol. 1: 799-807, 1990.